Drugs / NNC 0070-0002-0453
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01044108 | Jan → Dec 2010 | metabolic disease, obesity disorder | Novo Nordisk A/S | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NNC 0070-0002-0453 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01044108 ↗ |
| Known as | '2-0453 | “Drug: '2-0453” NCT01044108 ↗ |
| Route | Subcutaneous | “Administration of a single subcutaneous (under the skin) dose.” NCT01044108 ↗ |